Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01867242 · ClinicalTrials.gov registry record · NA
Methods Project 4: Clinical Trial
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT01867242 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 150 participants.
The verdict
NCT01867242, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
Cigarette smokers who are eligible will enter a Camel Snus sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and will then be randomized to one of the three experimental conditions for 8 weeks. Tobacco use patterns, subjective responses to product, and nicotine and toxicant exposure will be assessed.
Interventions
- OTHER Cigarettes
- OTHER Snus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2013-07 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01867242
The ClinicalTrials.gov registry entry for NCT01867242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cigarettes is the first listed.
NCT01867242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01867242 about?
NCT01867242 is a clinical study titled "Methods Project 4: Clinical Trial". Cigarette smokers who are eligible will enter a Camel Snus sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and will then be randomized to one of the three experimental conditions for 8 weeks. Tobacco use pattern...
What is the current status of trial NCT01867242?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2013-07. Estimated completion is 2018-05.
What interventions are being tested in trial NCT01867242?
The interventions under investigation include: Cigarettes (OTHER), Snus (OTHER).
Who is sponsoring clinical trial NCT01867242?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.